{
 "cells": [
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "# CDER NME "
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-07-23T03:42:38.488522Z",
     "start_time": "2024-07-23T03:42:38.397370Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import pandas as pd\n",
    "from drug_nme import FDAScraper"
   ],
   "outputs": [],
   "execution_count": 1
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-07-23T03:42:38.776225Z",
     "start_time": "2024-07-23T03:42:38.489369Z"
    }
   },
   "cell_type": "code",
   "source": [
    "scrape = FDAScraper()\n",
    "\n",
    "links = scrape.get_pdf_links()"
   ],
   "outputs": [],
   "execution_count": 2
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-07-23T03:42:38.780913Z",
     "start_time": "2024-07-23T03:42:38.777279Z"
    }
   },
   "cell_type": "code",
   "source": "links",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'2023': 'https://www.fda.gov/media/177083/download?attachment',\n",
       " '2022': 'https://www.fda.gov/media/165828/download?attachment',\n",
       " '2021': 'https://www.fda.gov/media/158152/download?attachment',\n",
       " '2020': 'https://www.fda.gov/media/147400/download?attachment',\n",
       " '2019': 'https://www.fda.gov/media/147414/download?attachment',\n",
       " '2018': 'https://www.fda.gov/media/124809/download?attachment',\n",
       " '2017': 'https://www.fda.gov/media/110746/download',\n",
       " '2016': 'https://www.fda.gov/media/102967/download',\n",
       " '2015': 'https://www.fda.gov/media/93424/download'}"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 3
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-07-23T03:42:39.708998Z",
     "start_time": "2024-07-23T03:42:38.782354Z"
    }
   },
   "cell_type": "code",
   "source": "table = scrape.extract_table(year='2023')",
   "outputs": [],
   "execution_count": 4
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-07-23T03:42:41.364757Z",
     "start_time": "2024-07-23T03:42:39.709760Z"
    }
   },
   "cell_type": "code",
   "source": [
    "tables = []\n",
    "\n",
    "for year, table in links.items():\n",
    "    data = scrape.extract_table(year=year)\n",
    "    tables.append(data)"
   ],
   "outputs": [],
   "execution_count": 5
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-07-23T03:42:41.374888Z",
     "start_time": "2024-07-23T03:42:41.365746Z"
    }
   },
   "cell_type": "code",
   "source": [
    "tables = pd.concat(tables, ignore_index=True)\n",
    "tables"
   ],
   "outputs": [
    {
     "data": {
      "text/plain": [
       "    APPLICATION NUMBER PROPRIETARY NAME ESTABLISHED NAME  \\\n",
       "0           NDA 214373        BRENZAVVY    BEXAGLIFLOZIN   \n",
       "1           NDA 216059         JAYPIRCA    PIRTOBRUTINIB   \n",
       "2           NDA 217639          ORSERDU      ELACESTRANT   \n",
       "3           NDA 216951        JESDUVROQ      DAPRODUSTAT   \n",
       "4           NDA 216403         FILSPARI       SPARSENTAN   \n",
       "..                 ...              ...              ...   \n",
       "300     BLA 125526/0.0           NUCALA      MEPOLIZUMAB   \n",
       "301     BLA 761036/0.0         DARZALEX      DARATUMUMAB   \n",
       "302     BLA 125547/0.0        PORTRAZZA      NECITUMUMAB   \n",
       "303     BLA 761035/0.0        EMPLICITI       ELOTUZUMAB   \n",
       "304     BLA 125561/0.0           KANUMA  SEBELIPASE ALFA   \n",
       "\n",
       "                                             APPLICANT REVIEW CLASSIFICATION  \\\n",
       "0                                      THERACOSBIO LLC                     S   \n",
       "1                                    LOXO ONCOLOGY INC                   P,O   \n",
       "2                            STEMLINE THERAPEUTICS INC                     P   \n",
       "3    GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD...                     S   \n",
       "4                             TRAVERE THERAPEUTICS INC                   P,O   \n",
       "..                                                 ...                   ...   \n",
       "300                                GLAXOSMITHKLINE LLC                     S   \n",
       "301                              JANSSEN BIOTECH, INC.                   P,O   \n",
       "302                              ELI LILLY AND COMPANY                     S   \n",
       "303                       BRISTOL-MYERS SQUIBB COMPANY                   P,O   \n",
       "304                            SYNAGEVA BIOPHARMA CORP                   P,O   \n",
       "\n",
       "    APPROVAL DATE                                         INDICATION  \\\n",
       "0       1/20/2023  ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEM...   \n",
       "1       1/27/2023  FOR THE TREATMENT OF ADULT PATIENTS WITH RELAP...   \n",
       "2       1/27/2023  FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN OR A...   \n",
       "3        2/1/2023  FOR THE TREATMENT OF ANEMIA DUE TO CHRONIC KID...   \n",
       "4       2/17/2023  TO REDUCE PROTEINURIA IN ADULTS WITH PRIMARY I...   \n",
       "..            ...                                                ...   \n",
       "300     11/4/2015  INDICATED FOR THE ADD-ON MAINTENANCE TREATMENT...   \n",
       "301    11/16/2015  INDICATED FOR TREATMENT OF PATIENTS WITH MULTI...   \n",
       "302    11/24/2015  IS INDICATED, IN COMBINATION WITH GEMCITABINE ...   \n",
       "303    11/30/2015  INDICATED IN COMBINATION WITH LENALIDOMIDE AND...   \n",
       "304     12/8/2015  INDICATED FOR THE TREATMENT OF PATIENTS WITH A...   \n",
       "\n",
       "    CY 2020 CDER New Molecular Entity (NME) Drug & Original BLA Calendar Year Approvals\\rAs of Decemeber 31, 2020\\rThis report reflects the data shown as it is identified in the database.\\rSelection Criteria:\\rUser Response: Start Date: 1/1/2020    End Date: 12/31/2020\\rSort Order: Approval Date  \\\n",
       "0                                                  NaN                                                                                                                                                                                                                                                     \n",
       "1                                                  NaN                                                                                                                                                                                                                                                     \n",
       "2                                                  NaN                                                                                                                                                                                                                                                     \n",
       "3                                                  NaN                                                                                                                                                                                                                                                     \n",
       "4                                                  NaN                                                                                                                                                                                                                                                     \n",
       "..                                                 ...                                                                                                                                                                                                                                                     \n",
       "300                                                NaN                                                                                                                                                                                                                                                     \n",
       "301                                                NaN                                                                                                                                                                                                                                                     \n",
       "302                                                NaN                                                                                                                                                                                                                                                     \n",
       "303                                                NaN                                                                                                                                                                                                                                                     \n",
       "304                                                NaN                                                                                                                                                                                                                                                     \n",
       "\n",
       "    Unnamed: 1_level_0 Unnamed: 2_level_0 Unnamed: 3_level_0  \\\n",
       "0                  NaN                NaN                NaN   \n",
       "1                  NaN                NaN                NaN   \n",
       "2                  NaN                NaN                NaN   \n",
       "3                  NaN                NaN                NaN   \n",
       "4                  NaN                NaN                NaN   \n",
       "..                 ...                ...                ...   \n",
       "300                NaN                NaN                NaN   \n",
       "301                NaN                NaN                NaN   \n",
       "302                NaN                NaN                NaN   \n",
       "303                NaN                NaN                NaN   \n",
       "304                NaN                NaN                NaN   \n",
       "\n",
       "    Unnamed: 4_level_0 Unnamed: 5_level_0 Unnamed: 6_level_0  \\\n",
       "0                  NaN                NaN                NaN   \n",
       "1                  NaN                NaN                NaN   \n",
       "2                  NaN                NaN                NaN   \n",
       "3                  NaN                NaN                NaN   \n",
       "4                  NaN                NaN                NaN   \n",
       "..                 ...                ...                ...   \n",
       "300                NaN                NaN                NaN   \n",
       "301                NaN                NaN                NaN   \n",
       "302                NaN                NaN                NaN   \n",
       "303                NaN                NaN                NaN   \n",
       "304                NaN                NaN                NaN   \n",
       "\n",
       "    Unnamed: 7_level_0  \\\n",
       "0                  NaN   \n",
       "1                  NaN   \n",
       "2                  NaN   \n",
       "3                  NaN   \n",
       "4                  NaN   \n",
       "..                 ...   \n",
       "300                NaN   \n",
       "301                NaN   \n",
       "302                NaN   \n",
       "303                NaN   \n",
       "304                NaN   \n",
       "\n",
       "    CY 2018 CDER New Molecular Entity (NME) Drug & Original BLA Calendar Year Approvals\\rAs of December 31, 2018\\rThis report reflects the data shown as it is identified in the database.\\rSelection Criteria:\\rUser Response: Start Date: 1/1/2018    End Date: 12/31/2018\\rSort Order: Approval Date  \n",
       "0                                                  NaN                                                                                                                                                                                                                                                   \n",
       "1                                                  NaN                                                                                                                                                                                                                                                   \n",
       "2                                                  NaN                                                                                                                                                                                                                                                   \n",
       "3                                                  NaN                                                                                                                                                                                                                                                   \n",
       "4                                                  NaN                                                                                                                                                                                                                                                   \n",
       "..                                                 ...                                                                                                                                                                                                                                                   \n",
       "300                                                NaN                                                                                                                                                                                                                                                   \n",
       "301                                                NaN                                                                                                                                                                                                                                                   \n",
       "302                                                NaN                                                                                                                                                                                                                                                   \n",
       "303                                                NaN                                                                                                                                                                                                                                                   \n",
       "304                                                NaN                                                                                                                                                                                                                                                   \n",
       "\n",
       "[305 rows x 16 columns]"
      ],
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>APPLICATION NUMBER</th>\n",
       "      <th>PROPRIETARY NAME</th>\n",
       "      <th>ESTABLISHED NAME</th>\n",
       "      <th>APPLICANT</th>\n",
       "      <th>REVIEW CLASSIFICATION</th>\n",
       "      <th>APPROVAL DATE</th>\n",
       "      <th>INDICATION</th>\n",
       "      <th>CY 2020 CDER New Molecular Entity (NME) Drug &amp; Original BLA Calendar Year Approvals\\rAs of Decemeber 31, 2020\\rThis report reflects the data shown as it is identified in the database.\\rSelection Criteria:\\rUser Response: Start Date: 1/1/2020    End Date: 12/31/2020\\rSort Order: Approval Date</th>\n",
       "      <th>Unnamed: 1_level_0</th>\n",
       "      <th>Unnamed: 2_level_0</th>\n",
       "      <th>Unnamed: 3_level_0</th>\n",
       "      <th>Unnamed: 4_level_0</th>\n",
       "      <th>Unnamed: 5_level_0</th>\n",
       "      <th>Unnamed: 6_level_0</th>\n",
       "      <th>Unnamed: 7_level_0</th>\n",
       "      <th>CY 2018 CDER New Molecular Entity (NME) Drug &amp; Original BLA Calendar Year Approvals\\rAs of December 31, 2018\\rThis report reflects the data shown as it is identified in the database.\\rSelection Criteria:\\rUser Response: Start Date: 1/1/2018    End Date: 12/31/2018\\rSort Order: Approval Date</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NDA 214373</td>\n",
       "      <td>BRENZAVVY</td>\n",
       "      <td>BEXAGLIFLOZIN</td>\n",
       "      <td>THERACOSBIO LLC</td>\n",
       "      <td>S</td>\n",
       "      <td>1/20/2023</td>\n",
       "      <td>ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NDA 216059</td>\n",
       "      <td>JAYPIRCA</td>\n",
       "      <td>PIRTOBRUTINIB</td>\n",
       "      <td>LOXO ONCOLOGY INC</td>\n",
       "      <td>P,O</td>\n",
       "      <td>1/27/2023</td>\n",
       "      <td>FOR THE TREATMENT OF ADULT PATIENTS WITH RELAP...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NDA 217639</td>\n",
       "      <td>ORSERDU</td>\n",
       "      <td>ELACESTRANT</td>\n",
       "      <td>STEMLINE THERAPEUTICS INC</td>\n",
       "      <td>P</td>\n",
       "      <td>1/27/2023</td>\n",
       "      <td>FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN OR A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NDA 216951</td>\n",
       "      <td>JESDUVROQ</td>\n",
       "      <td>DAPRODUSTAT</td>\n",
       "      <td>GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD...</td>\n",
       "      <td>S</td>\n",
       "      <td>2/1/2023</td>\n",
       "      <td>FOR THE TREATMENT OF ANEMIA DUE TO CHRONIC KID...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NDA 216403</td>\n",
       "      <td>FILSPARI</td>\n",
       "      <td>SPARSENTAN</td>\n",
       "      <td>TRAVERE THERAPEUTICS INC</td>\n",
       "      <td>P,O</td>\n",
       "      <td>2/17/2023</td>\n",
       "      <td>TO REDUCE PROTEINURIA IN ADULTS WITH PRIMARY I...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>BLA 125526/0.0</td>\n",
       "      <td>NUCALA</td>\n",
       "      <td>MEPOLIZUMAB</td>\n",
       "      <td>GLAXOSMITHKLINE LLC</td>\n",
       "      <td>S</td>\n",
       "      <td>11/4/2015</td>\n",
       "      <td>INDICATED FOR THE ADD-ON MAINTENANCE TREATMENT...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>BLA 761036/0.0</td>\n",
       "      <td>DARZALEX</td>\n",
       "      <td>DARATUMUMAB</td>\n",
       "      <td>JANSSEN BIOTECH, INC.</td>\n",
       "      <td>P,O</td>\n",
       "      <td>11/16/2015</td>\n",
       "      <td>INDICATED FOR TREATMENT OF PATIENTS WITH MULTI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>BLA 125547/0.0</td>\n",
       "      <td>PORTRAZZA</td>\n",
       "      <td>NECITUMUMAB</td>\n",
       "      <td>ELI LILLY AND COMPANY</td>\n",
       "      <td>S</td>\n",
       "      <td>11/24/2015</td>\n",
       "      <td>IS INDICATED, IN COMBINATION WITH GEMCITABINE ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>BLA 761035/0.0</td>\n",
       "      <td>EMPLICITI</td>\n",
       "      <td>ELOTUZUMAB</td>\n",
       "      <td>BRISTOL-MYERS SQUIBB COMPANY</td>\n",
       "      <td>P,O</td>\n",
       "      <td>11/30/2015</td>\n",
       "      <td>INDICATED IN COMBINATION WITH LENALIDOMIDE AND...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>BLA 125561/0.0</td>\n",
       "      <td>KANUMA</td>\n",
       "      <td>SEBELIPASE ALFA</td>\n",
       "      <td>SYNAGEVA BIOPHARMA CORP</td>\n",
       "      <td>P,O</td>\n",
       "      <td>12/8/2015</td>\n",
       "      <td>INDICATED FOR THE TREATMENT OF PATIENTS WITH A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>305 rows Ã— 16 columns</p>\n",
       "</div>"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 6
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.16"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
